Premium Nahrungsergänzungsmittel | artgerecht

Bone Resorption Markers – Definition and Significance

Bone resorption markers are laboratory values that measure the breakdown of bone tissue. They help physicians detect conditions such as osteoporosis early and monitor the effectiveness of treatment.

Regular tips about health Regular tips about health

Things worth knowing about "Bone resorption markers"

Bone resorption markers are laboratory values that measure the breakdown of bone tissue. They help physicians detect conditions such as osteoporosis early and monitor the effectiveness of treatment.

What are bone resorption markers?

Bone resorption markers (also called bone degradation markers) are biochemical substances released during the breakdown of bone tissue that can be detected in blood or urine. Bone is not a static organ – it is continuously renewed throughout life in a process known as bone remodeling. When resorption (breakdown) persistently exceeds bone formation, the skeleton loses density and structural strength.

Which markers are measured?

Several bone resorption markers are used in clinical diagnostics:

CTX-I (C-terminal telopeptide of type I collagen): The most widely used and recommended marker, measured in blood serum. It reflects the current breakdown of type I collagen – the main structural protein of bone.
NTX-I (N-terminal telopeptide of type I collagen): Can be measured in urine or serum and also indicates the rate of bone resorption.
DPD (deoxypyridinoline): A collagen cross-link degradation product detected in urine, specific to bone and cartilage tissue.
PYD (pyridinoline): Similar to DPD but less bone-specific, as it also occurs in other connective tissues.
TRAP 5b (tartrate-resistant acid phosphatase 5b): An enzyme produced by osteoclasts – the cells responsible for bone breakdown – directly reflecting their activity.

When are bone resorption markers used?

Bone resorption markers are measured in a variety of clinical situations:

Diagnosis and monitoring of osteoporosis
Monitoring the effectiveness of bone-protective medications (e.g., bisphosphonates, denosumab)
Evaluation of conditions associated with increased bone loss, such as Paget's disease of bone, multiple myeloma, or bone metastases
Follow-up after fracture or bone surgery
Assessment of bone loss related to hormonal changes (e.g., menopause)

How is the measurement performed?

Most bone resorption markers are measured from a blood sample (serum) or a urine sample. Because many markers show significant diurnal variation, blood should ideally be drawn in the fasting state in the morning. CTX-I, for example, is best measured between 7:00 and 10:00 a.m. Recent physical activity, food intake, and time of day can all influence the results.

Interpretation of results

Elevated bone resorption markers may indicate accelerated bone breakdown. However, increased values are not automatically pathological and can also occur in:

Growth phases in children and adolescents
The postmenopausal period
Prolonged immobility
Certain medications (e.g., glucocorticoids)

Results must therefore always be interpreted in the overall clinical context and in conjunction with other findings, such as bone mineral density measurement (DXA scan).

Clinical importance and treatment monitoring

Bone resorption markers are particularly valuable for treatment monitoring: Under successful therapy with bisphosphonates or other antiresorptive agents, marker levels decline significantly within weeks to months. This allows early assessment of treatment response, long before changes in bone density become measurable.

References

Szulc, P. et al. (2017): Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporosis International, 28(9), 2541–2556.
Eastell, R. et al. (2011): Bone markers. Osteoporosis International, 22(Suppl 3), 793–799.
World Health Organization (WHO): Assessment of osteoporosis at the primary health care level. Summary Report of a WHO Scientific Group. Geneva: WHO Press, 2007.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.